EichorEICHOR
Location: Linfen Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Linfen

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Phase 2 · Linfen Central Hospital · Kunming Pharmaceuticals, Inc. · NCT07279493A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)
Phase 2 · Linfen Central Hospital · InventisBio Co., Ltd · NCT07311200A Study of MI078 for Postpartum Depression
Phase 3 · Linfen Central Hospital · Nanjing Minova Pharmaceutical Co., Ltd. · NCT07721961Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
Phase 3 · Linfen Central Hospital · Beijing Tiantan Hospital · NCT06157502A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treat
Phase 3 · Research Site · AstraZeneca · NCT06764875Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Phase 2/Phase 3 · Corxel Investigational Site · Corxel Pharmaceuticals · NCT06990867Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Phase 3 · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07107256Neuroendoscopy-assisted Drainage Versus Burr Hole Drainage for Chronic Subdural Hematoma
NA · Linfen People's Hospital · Beijing Tiantan Hospital · NCT07144423Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Phase 2 · Linfen Central hospital · Atom Therapeutics Co., Ltd · NCT07145229A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Phase 2 · Linfen Central Hospital · Boehringer Ingelheim · NCT07409181A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus
Phase 2 · LinFen Central Hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07509892Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke
Phase 3 · Linfen Central Hospital · Shanghai Hutchison Pharmaceuticals Limited · NCT07241520A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiography
Phase N/A · Linfen People's Hospital · First Hospital of China Medical University · NCT07133516A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR20
Phase 3 · Linfen Central Hospital · Genrix (Shanghai) Biopharmaceutical Co., Ltd. · NCT06635798Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular T
Phase 2 · Linfen Central Hospital · Shanghai QuietD Biotechnology Co., Ltd. · NCT07581210A Study of SCTB35 in Patients with Systemic Lupus Erythematosus
Phase 1/Phase 2 · Linfen Central Hospital · Sinocelltech Ltd. · NCT06841042JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcino
Phase 3 · Linfen central hospital · Shanghai Junshi Bioscience Co., Ltd. · NCT07284134A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Pe
Phase 3 · Linfen Central Hospital · Boehringer Ingelheim · NCT07361302Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
Phase 2 · Linfen Central Hospital · Shanghai Pharmaceuticals Holding Co., Ltd · NCT05686642A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a
Phase 3 · Linfen Central Hospital · Boehringer Ingelheim · NCT06935370A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Phase 3 · Linfen Central Hospital · Boehringer Ingelheim · NCT06424288A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Phase 3 · Linfen Central Hospital · Janssen Research & Development, LLC · NCT07438496A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
Phase 2 · Linfen Central Hospital · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07406035Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis
Phase 2 · Linfen Central Hospital · Toll Biotech Co. Ltd. (Beijing) · NCT07408024A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Par
Phase 3 · Linfen Central Hospital · Janssen Research & Development, LLC · NCT06807424A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and
Phase 3 · Linfen Central Hospital · Biocells (Beijing) Biotech Co.,Ltd · NCT07520565
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.